The “2025 Taiwan Medical & Wellness Expo – Dubai Edition” was successfully held on October 4–5, 2025, at Capital Club Dubai in DIFC. Co-organized by Aivita Health Group and Axel Biotechnology Inc., the event gathered key figures from the Middle East’s medical, academic, and investment sectors to explore advancements in precision medicine and regenerative healthcare.

October 4 – Precision Medicine 

The first day centered on Precision Medicine, with leading Taiwanese biotech companies presenting their R&D breakthroughs and global collaboration strategies.

October 5 – Regenerative Medicine 

The second day highlighted regenerative medicine applications and Taiwan’s integration of exosome, stem cell, and smart healthcare technologies.

October 6 – Cross-Emirate Collaboration 

On October 6, facilitated by Aivita Health Group, the delegation achieved an unprecedented cross-emirate tour covering Ajman, Sharjah, and Dubai, fostering new collaborations in medical education, industrial investment, and clinical research.

October 7 – Strategic Expansion at DHA & Thumbay Hospital

In the morning of October 7, the delegation visited the Dubai Health Authority (DHA) to attend an official investment and innovation briefing. Taiwanese exhibitors presented their cutting-edge R&D and clinical solutions, strengthening engagement with Dubai’s healthcare leadership.

In the afternoon, the team revisited Ajman Thumbay Hospital for in-depth meetings with hospital executives, discussing multidisciplinary clinical collaborations, education programs, and technology transfer—establishing a long-term cooperative framework.

Conclusion

Across four days and three emirates, the Taiwan Medical & Wellness Delegation demonstrated exceptional agility and innovation in AI-driven precision medicine and regenerative science. Through continuous engagement and strategic partnerships, Taiwan and the UAE are poised to embark on a new era of collaboration in healthcare technology, education, and investment.